In all four samples from patients with active MS lesions as well as in one patient with the Marburg variant of MS who died of the disease 14 days after onset, we found a dense infiltrate of CD68+HLA-DR+ myeloid cells that stained predominantly positive for SIGLEC1 (Fig. 2a). This evidence concerns the gene CD68 and myeloid sarcoma.